Advertisement

Kongreß pp 223-230 | Cite as

Neue Konzepte zur Pathogenese der primären Hypertonie

  • A. Distler
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 93)

Zusammenfassung

Es hat in der Vergangenheit immer wieder Bestrebungen gegeben, die essentielle Hypertonie auf eine bestimmte Ursache, beispielsweise auf die vermehrte Bildung eines Hemmstoffs der Natrium-Kalium-ATPase [9], zurückzuführen. Bis heute ließ sich jedoch kein Faktor identifizieren, der allein für die Pathogenese der essentiellen Hypertonie verantwortlich gemacht werden könnte. Vielmehr muß davon ausgegangen werden, daß bei der essentiellen Hypertonie eine multifaktorielle Genese vorliegt, wobei je nach Vorliebe des einzelnen Forschers bestimmte Faktoren als besonders bedeutsam herausgestellt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Blaustein MP (1974) The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol 70: 33–82PubMedCrossRefGoogle Scholar
  2. 2.
    Boon NA, Elliot JM, Davies CL, Conway FJ, Grahame-Smith DG, Sleight P (1983) Platelet alpha-adrenoceptors in borderline and established essential hypertension. Clin Sci 64: 265Google Scholar
  3. 3.
    Brodde OE, Prywarra A, Anlauf M, Daul A, Bock KD (1983) Increased number of ß2-adrenoceptors in circulating lymphocytes of patients with essential hypertension. J Hypertension 1 [Suppl 2]: 262–266Google Scholar
  4. 4.
    Brodde OE, Stuka N, Demuth V, Fesel R, Bergerhausen J, Daul A, Bock KD (1985) Alpha- and beta-adrenoeeptors in circulating blood cells of essential hypertensive patients: increased reeeptor density and responsiveness. Clin Exp Hypertension A7: 1135–1150CrossRefGoogle Scholar
  5. 5.
    Bruschi G, Orlandini G, Pavarani C, Spaggiari M, Tacinell L, Cavatorta A (1984) Lymphocytic beta-adrenoeeptor abnormality in primary hypertension. IRCS Med Sci 12: 461–462Google Scholar
  6. 6.
    Bruschi G, Bruschi ME, Caroppo M, Orlandini G, Spaggiari M, Cavatorta A (1985) Cytoplasmic free (Ca2+) is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin Sci 68: 179–184PubMedGoogle Scholar
  7. 7.
    Conway J (1963) A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation 27: 520–529PubMedGoogle Scholar
  8. 8.
    Cooper RS, Shamsi N, Katz S (1987) Intracellular calcium and sodium in hyper¬tensive patients. Hypertension 9: 224–229PubMedGoogle Scholar
  9. 9.
    De Wardener HE, Mac Gregor GA (1983) The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine (Baltimore) 62: 310–326Google Scholar
  10. 10.
    Distler A (1984) Vasopressorhormone und Hypertonie. In: Miehlke K (Hrsg) Verhandlungen der Deutschen Gesellschaft für Innere Medizin, 90. Band. Bergmann, München, pp 58–64Google Scholar
  11. 11.
    Doyle AE, Fräser JRE, Marshall RJ (1959) Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects. Clin Sei 18: 441–454Google Scholar
  12. 12.
    Doyle V, O’MalleyK, Kelly JG (1982) Human lymphocyte ß-adrenoeeptor density in relation of age and hypertension. J Cardvasc Pharmacol 4: 738–740Google Scholar
  13. 13.
    Erne P, Bolli P, Bürgisser E, Bühler FR (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med 310: 1084–1088Google Scholar
  14. 14.
    Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ (1984) Leukocyte ß-reeeptor alterations in hypertensive subjects. J Clin Invest 73: 648–653PubMedCrossRefGoogle Scholar
  15. 15.
    Folkow B, Grimby G, Thulesius O (1958) Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 44: 255–272PubMedCrossRefGoogle Scholar
  16. 16.
    Folkow B (1983) Personal views on the mechanisms of primary hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M (eds) Hypertension. Physiopathology and treatment. McGraw-Hill, New York, pp 646–659Google Scholar
  17. 17.
    Fritschka E, Kribben A, Hoyer J, Thiede HM, Distler A, Philipp Th (1987) Genetischer Einfluß auf Alpha2-Rezeptoren und Ade- nylzyklaseaktivität bei Normotonikern und Hypertonikern (im Druck)Google Scholar
  18. 18.
    Haller H, Lenz T, Thiede M, Lüdersdorf M, Kribben A, Distler A, Philipp Th (1987) Platelet intracellular free calcium and hypertension. J Clin Hypertens 3: 12–19PubMedGoogle Scholar
  19. 19.
    Hollister AS, Onrot J, Lonce S, Nadeau JHJ, Robertson D (1986) Plasma catecholamine modulation of alpha2 adrenoeeptor agonist affin- ity and sensitivity in normontensive and hypertensive human platelets. J Clin Invest 77: 1416–1421PubMedCrossRefGoogle Scholar
  20. 20.
    Hulthen UL, Bolli P, Bühler FR (1983) Calcium influx mediated vasoconstriction: Studies in patients with mild and moderate essential hypertension. J Hypertens 1 [Suppl 2]: 105–108Google Scholar
  21. 21.
    Hulthen UL, Bolli P, Bühler FR (1985) Vasodilatory effect of nicardipine and Verapamil in the forearm of hypertensive as compared with normotensive man. Br J Clin Pharmacol 20: 62S–66SPubMedGoogle Scholar
  22. 22.
    Kafka MS, Lake CR, Gullner HG, Tallmann, JF, Bartter FC, Fujita T (1979) Adrenergic reeeptor funetion is different in male and female patients with essential hypertension. clin Exp Hypertension 1: 613–627Google Scholar
  23. 23.
    Kuriyama H, Ito Y, Suzuki H, Kitamura K, Itoh T (1982) Factors modifying concentration- relaxation cycle in vascular smooth muscles. Am J Physiol 243-. H641–662Google Scholar
  24. 24.
    Landmann R, Bürgisser E, Bühler FR (1983) Human lymphocytes as a model for beta-adrenergic reeeptors in clinical investigation. J Ree Res 3: 71–88Google Scholar
  25. 25.
    Le Quan Sang KH, Devynck M-A (1986) Increased platelet cytosolic free calcium concentration in essential hyperten¬sion. J Hypertension 4: 567–574CrossRefGoogle Scholar
  26. 26.
    Lechi A, Lechi C, Bonadonna G, Sinigaglia D, Corradinie P, Polignano R, Arosio E, Covi G, de Togni P (1987) Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients. Hypertension 9: 230–235PubMedGoogle Scholar
  27. 27.
    Lindner A, Kenny M, Meacham AJ (1987) Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med 316: 509–513PubMedCrossRefGoogle Scholar
  28. 28.
    Middeke M, Remien J, Block LH, Kirzinger S, Landrock A, Holzgreve H (1983) Beta2-adrenoceptor density on membranes and on intact mononuclear cells in essential hypertension. Res Exp Med 183: 227–232CrossRefGoogle Scholar
  29. 29.
    Motulsky HJ, O’Connor DT, Insel P (1983) Platelet alpha2-adrenergic reeeptors in treated and untreated essential hypertension. Clin Sei 64: 265–272Google Scholar
  30. 30.
    Ogilvie R, Nadeau J, Lutterodt A (1982) Vasodilator capacity of forearm vessels in hypertension. Clin Exp Hypertens A4: 1391–1407CrossRefGoogle Scholar
  31. 31.
    Philipp Th, Distler A, Cordes U (1978) Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet 1: 595–963Google Scholar
  32. 32.
    Rasmussen H (1986) The calcium messenger system. N Engl J Med 314:1094–1101, 1164–1170Google Scholar
  33. 33.
    Robinson BF, Dobbs RJ, Bayley S (1982) Response of forearm resistance vessels to Verapamil and sodium nitro- prusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci 63: 33–42PubMedGoogle Scholar
  34. 34.
    Sannerstedt R, Sivertsson R, Lundgren Y (1976) Haemodynamic studies in young men with mild blood pressue elevation. Acta Med Scand 602 [Suppl]: 61–67Google Scholar
  35. 35.
    Schulte KL, Braun J, Meyer-Sabellek W, Götzen R, distler A (1986) Functional abnormality of forearm vascular smooth muscle in essential hypertension: effects of reactive hyperemia, nifedipine and sodium nitroprusside. J Hypertens 4 [Suppl 6] (in press)Google Scholar
  36. 36.
    Sivertsson R (1970) The hemodynamic importance of structural vascular changes in essential hypertension. Acta Physiol Scand 343 [Suppl] 1–56Google Scholar
  37. 37.
    Takeshita A, Mark AL (1980) Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 2: 610–616PubMedGoogle Scholar
  38. 38.
    Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M (1982) Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a familial predisposition to hypertension. Circ Res 50: 671–677PubMedGoogle Scholar
  39. 39.
    Vlachakis ND (1979) Blood pressure response to norepinephrine infusion in relation to plasma catecholamines and renin activity in man. J Clin Pharmacol 19: 654–661PubMedGoogle Scholar
  40. 40.
    Weidmann P, Grimm M, Meier A, Glück Z, Keusch G, Minder I, Beretta-Piccoli C (1980) Pathogenetic and therapeutic signifi- cance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension. Clin Exp Hypertens 2: 427–449PubMedCrossRefGoogle Scholar

Copyright information

© J. F. Bergmann Verlag, München 1987

Authors and Affiliations

  • A. Distler
    • 1
  1. 1.Abteilung für allgemeine Innere Medizin und Nephrologie, Klinikum SteglitzFreien Universität BerlinDeutschland

Personalised recommendations